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I. DEVELOPMENT OF A BOVINE LIVER CELL-FREE SYSTEM
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Department of Biochemistry, Biomedical Centre, State Uniuersity Limburg, Maastricht
(The Netherlands)
(Received June 14th, 1976)
Summary
Purified PIVKA-II is converted into prothrombin by a cell-free system
derived from normal bovine liver.
The reaction conditions are described.
In the absence of vitamin K many mammals generate proteins (PIVKAs)
which axe immunologically identical to the vitamin K-dependent clotting
factors but which lack thet functional activity [1]. At the moment of their
discovery in 1963 121 It was already supposed that PIVKAs were precursors
of the vitamin K-dependent coagulation factors. After the discovery by
Stenflo and coworkers [3] that the 7-calboxyl gloups present in 10 glutamic
acid residues of prothrombin account for the difference between PMA-II
and prothrombin, it was to be expected that the vitamin K-dependent system
brought ahout the carboxylation of PIVKA.
Suttie and coworkers [4,5] showed that liver microsomes from vitamin
K-deficient rats mediate in the incorporation of l4C-Iabeled COz and generate
factor II activity, supposedly from an endogenous plecursor. In the present
paper we describe the conversion of purified PIVKA-II into prothrombin by
a cell-free system derived from normal bovine liver.
A. The preparation of the actiue microsome fraction
Crude liver microsomes from freshly slaughtered healthy cows prepared
according to Shah and Suttie [4] did not show any prothrombin synthesizing
activity. Fractionation on a DEAE-cellulose column showed a separation
between fractions containing prothrombin activity and fractions containing a
prothrombin inhibitor activity (Fig. 1A). Centrifugation of the crude prepara-
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Fig. 1. Chromatogiaphy of ttrree types of microsomei. About 1OO g of fresh boirine liver was cut into'
pieces of 5 g each, rinsed with ibe-cold buffer G (O.2 M sucrose, O.Ob M KCl, O.O2 M Tris.HCl, pE ?.8)
and mixed irr a Waring Blendor vrith 3OO ml of buffer G. The sluny was homogenized furthef irf a
Potter homogenizer with a tight-fitting teflon pestle and centrifuged two times for 15 min at 12 OO0 X C.
The supernatant was centrifuged for 3O min at 150 OO0 X g. Two-third of tlxe upper layer was taken
for the prepeation of the "microsomal supernatant". The pellet was washed four times by re'suspending
in 3OO mI of buffer G and centrifuging for 3O min at 15O OOO X C. Finally the pellet was dissolved to
an absotbance of 320 absorbance units at 280 nm and refeued to as "crude microsomes". Prothronibin
was assayed as described earlier [6]. A. Crude microsomes from 3O g of liver were supplementtjd with .
Triton X-1OO to a final concentration of O.57o, incubated at O"C for 3O min and applied to a DEAE+eUulose
column (1 cm X.6O cm) in buffer H (O.O5 M NaCl, O.O2 M Tris.HCl, pH 7.8). The column was ri;aslied
witJ: buffer H atid eluted with a Iinear grad.ient from O to O.5 M NaCl in buffer H. Fractions of 4 ml were
couected, dialyzed against Michaelis buffer and assayed for prothrombin activity. fabtoi ff-iirtilititor "
activity was determined by the inhibition of a known mount of prothrombin in the one.stage
coagulation assay. Inhibitor activity in factor Il-containing ftactions was detected after BaSO; adsorption.
-, Absorbanc e at 28O nmi X - - -X , 
'Factor II activity; .---.r 
'Factor 
II inhibitor activity. B.' Crual€
microsomes were centrifuged for 2O min at 2O OOO X g. Tlxe pellet was dissolved in buffer H and
treated as described for crude microsomes in A. C. The 20 OOO X g supernatant was treated as described
for crude microsomes in A.
tzi! zt-
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tion for 20 min at 20 000 X g sedimented the microsomes containing the inhibi-
tors but left those containing factor II activity in the supernatant (Figs. 18 and
1-C). The latter microsomes we used in prothrombin synthesis experiments or as
a starting material for further purification of the PIVKA-II-converting enzyme.
B. The preparation of microsomal supernatant
In order to prepare cell sap devoid of contaminating prothrombin we
removed this factor from 150 000 x g microsomal supernatant by heating to
65'C for 30 min. The solution was centrifuged for 20 min at ZO OOO X g
before it was frozen and stored at -70'C.
C. The cell-free prothrombin synthesizing system
The microsomes and supernatant preparations were added to reaction
mixtures to a final concentration (v/v) of. L2.5vo and 16jvo, respectively. The
other components of the reaction mixtures were: pIVKA-II (0.2 U/ml)x,
ATP (2 mM), creatinine phosphate (5 mM), creatine phosphokinase
(50 pglmt), magnesium acetate (3.3 mM), NH4 HCO3 (20 mM), KCI (80 mM),
Tris.HClpH 8.5 (50 mM), sucrose (60 mM) and vitamin K1 (0.1b mg/ml). The
tubes containing the reaction mixtures (0.1 ml) were gassed for B0 seconds
with 02 and closed. Before and after incubation f.or 45 min at 37"C the factor
II activity was determined in four-fold diluted solutions with the aid of the
one-stage prothrombin assay [7] using a reagent devoid of any factor II
activity [6] 
**.
The increase in factor II activity during this period is expressed as the
percentage of PIVKA-II which is converted into factor II. with all reaction
components present about 3-5vo of the added PIVKA-II could routinely be
converted. when using less PIVKA-II the efficiency of the conversion could
TABLE I
THE REQUIREMENT OF VARIOUS COMPONENTS FOR THE CONVERSION OF PIVKA.II
INTO PROTHROMBIN
PIVKA-II was obtained from BaSO4 (200 mg/m-l) adsorbed plasma from coumuin-treated cows and
batchwise adsorbed onto DBAE-Sephadex which was washed with O.1O M NaCl and eluted with a
linear gradient from O.1O tro 0.5 M NaCl in 2O mM Tris.HCl, pH 7.5. The peak fractions were pooled.
dialyzed against 0.1 M NaCl, concentrated and stored at -7O"C, The values in the last column are
those obtained in the partlv purified system, Further details are described in the text.
Omission duing incubation Prothrombin synthesis (7o of maximal)
None
PIVKA-II
Mictosomes
Supernatant
ATP
Creatinine phosphate 'l
Creatinephosphokimse )
Magnesium acetate
Vitamin K
NH4HCO3
KCI
(saturation: 5%)
100
o
o
3 5
3 2
83
4L
86
44
90
38
(1oo)
( o )
( 4 )
(  33 )
( 22)
89)
10)
24)
47)
92)
38 )
'" 
one u of PIVKA-rI is defined as the amount of PIVKA-II which produces an equal amount of thrombin
**1"fidt" 
as 1 rnl of normal bovine plasma in the Echis Carinatus assay t6l.Amounts of 5.lO-" U/ml of factor II are easily detected in ihic assay.
(
(
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be enlarged up to more than gro, but in that case long clotting times wereobtained which were unpractical for routine tests. The effect of omission ofaly one of the components from the reaction mixture is shown in Table I. ThepH optimum of the reaction is between g an! 9. rne ryriem was not completerydependent on vitamin K1 which may be explained by assumin gthatendo-genous vitamin K, is present in the microsomes. Thil assumftion was sus-tained by experiments in which we partially purified trre pirixa-Il-converbing
enzyme: microsomes were desintegrated with 2To ofTliton x-100, extractedwith Freon 113 and applied to a DEAE-cellulose column in a buffer
containing 25 mM KCI and 10 mM Tris.HCl, pH ?.g. rne coiumn was elutedwith a linear gradient from 2b to b00 mM KCr, the fractions were dialyzed
and extracted once more with Freon 118. In this way a prefaration was ob_tained still containing all PIVKA-II activity but aeuoia ;i;; factor II activityin clotting and immunochemical assays. This preparatio'wus almost com-pletely dependent on vitamin K, as the factor Iliynthesis Jiopp"a to lessthan 25vo when the vitamin was omitted and to nii when vitamin K1 wasreplaced by 0.1 mM of warfarin.
The time-course of the generation of factor II activity in this system isshown in Fig. 2. It reached a maximum after about t houi. at o"c the in_crease was only very limited.
O 60 12O 18O time(min,
Fig' 2' The time-course of prothrombin synthesis. .-----, at B?oc; X-y, at ooc. Blank values (H.B%)containing o.1 mM of warfarin are substracted. Further details are described in the text.
The factor II activity which was formed during the incubation could beaf_so_rbed on Basoa and eluted therefrom with 0.06 M trisodium citrate atpH 5.8. RNAase (10 mg/mr) did not inhibit the reaction, ,rro*irre that 'RNAis not involved in this generation of factor II activity.
In order to rure out the possibility that the added PIVKA-II only served toneutralize an inhibitor thus permittinga small amount of precursor, presentin our system, to be expressed as or tJ be converted into prothrombin, wereplaced PIVKA-II by prothrombin derivatives (Table rry. rrrese derivativesalone did not induce any increase of factor It aciivity. Inthe presence ofPIVKA-II they slighfly decreased factor II synthesis.- 
'
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TABIJE I I , , , .  :  , :  I
STIMULATION OF PROTHROMBIN SYNTHESIS BY VARIOUS FACTOR II DERIVATIVES
Glutaraldehyde-treated factor II (Fattor II - Glu) was prepared by incubation of factor ll it lVo
Snutaraldehyde for 3O min at 37"C and subsequent dialysis. Oxidized factor II (Factor II - Ox) and
reduced-carboxymethilated factor II (Factor II - Red) were prepared according to ref. 8. No one of
these three factor II derifatives eontains any factor U activity. .
substrate added (U I 19?7ml) Prothrombin synthesis (U X 103/ml)
I
(
I
I
(
(
None
PrvKA-rr (15)
PMA-II (15) + i'3s1e1 11 11; 
*
Factor U (1)
PIVKA-II (15) + Eactor II - Glu (50)
PMA-II (15) + Factor II - Ox (5O)
PMA-II (15) + Factor U - Red (5O)
Factor II - GIu (5O)
Factor II - Ox (5O)
Factor II - Red (5O)
* t
8.9
9.1
6:8
6 .5
6 .9
*T'his 
amount ofrfactor II causes a compaiable clotting time as 0.15 U/ml of PMA-II.
As we were never able to detect the presence of thrombin [6] in our
reaction mixtures, the only explanation for the generation of factor II activity
in our system seems to be that PIVKA-II can be converted into prothrombin
by a fraction obtained from liver cells. This conversion is dependent upon
energy, vitamin K, oxygen, monovalent and bivalent ions, HCO3 
- 
and tem-
perature. As far as we know these experiments axe the first direct proof that
PIVKA-II can serve as a prothrombin precursor. The enzyme system
responsible for the conversion of PIVKA-II is expected to be a carboxylating
system unique in that it does not need biotin. Obviously purification of the
enzyme and further research will be necessarily to unravel the mechanism of
this reaction.
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